selected KIs
mathematical systems pharmacology models
Systems Pharmacology Kinase inhibitors
mathematical systems pharmacology modelling
Systems Biology
CT risk of new KIs
leading systems pharmacology group
therapeutic use of KIs
predictive CT signatures
dynamical models
fellow aims
selected proteins
different magnitudes of CT
Mount Sinai
protein expression
state-of-the-art experimental data generation
time
Training
network modelling
generation of predictive network
Cardiotoxicity
cardiomyocyte health markers
experimental technologies
New York
KI-induced
weighted signatures
serious adverse condition
innovative multi-disciplinary approach
effective anti-cancer drugs
identification of key regulatory proteins
clinical adverse event databases
changes
Leiden University
major class
future collaboration
effects
untargeted mRNA
independent researcher
Human cardiomyocytes
pluripotent stem cells
treatments
combination
career track
exposure
fellowship
Europe
relationship
project
experience